Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis
Open Access
- 24 April 2020
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 10 (4), 169
- https://doi.org/10.3390/metabo10040169
Abstract
While a complex network of cellular and molecular events is known to be involved in the pathophysiological mechanism of chronic kidney disease (CKD), the divergence point between reversal and progression and the event that triggers CKD progression are still unknown. To understand the different mechanisms between reversible and irreversible kidney disease and to search for urinary biomarkers that can predict prognosis, a metabolomic analysis was applied to compare acute and chronic experimental glomerulonephritis (GN) models. Four metabolites, namely, epoxyoctadecenoic acid (EpOME), epoxyeicosatetraenoic acid (EpETE), α-linolenic acid (ALA), and hydroxyretinoic acid, were identified as predictive markers after comparing the chronic nephritis model with acute nephritis and control groups (false discovery rate adjusted p-value (q-value) < 0.05). Renal mRNA expression of cytochrome P450 and epoxide hydrolase was also identified as being involved in the production of epoxide metabolites from these polyunsaturated fatty acids (p < 0.05). These results suggested that the progression of chronic kidney disease is associated with abnormally activated epoxide hydrolase, leading to an increase in EpOME and EpETE as pro-inflammatory eicosanoids.This publication has 89 references indexed in Scilit:
- α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertensionClinical Science, 2012
- Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platformActa Oncologica, 2012
- Enzymes of the AKR1B and AKR1C Subfamilies and Uterine DiseasesFrontiers in Pharmacology, 2012
- CYP-eicosanoids—A new link between omega-3 fatty acids and cardiac disease?Prostaglandins & Other Lipid Mediators, 2011
- Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia‐reperfusion injury in isolated mouse heartThe FASEB Journal, 2011
- High Potassium Intake Enhances the Inhibitory Effect of 11,12-EET on ENaCJournal of the American Society of Nephrology, 2010
- Structures of Human Cytochrome P-450 2E1Online Journal of Public Health Informatics, 2008
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976